|
1
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Heighway J and Betticher DC: Lung tumors:
an overview. Atlas Genet Cytogenet Oncol Haematol. 8:139–141.
2004.
|
|
3
|
Ramalingam SS, Owonikoko TK and Khuri FR:
Lung cancer: New biological insights and recent therapeutic
advances. CA Cancer J Clin. 61:91–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel R, DeSantis C, Virgo K, Stein K,
Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Morgensztern D, Ng SH, Gao F and Govindan
R: Trends in stage distribution for patients with non-small cell
lung cancer: A National Cancer Database survey. J Thorac Oncol.
5:29–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seewaldt VL, Johnson BS, Parker MB,
Collins SJ and Swisshelm K: Expression of retinoic acid receptor
beta mediates retinoic acid-induced growth arrest and apoptosis in
breast cancer cells. Cell Growth Differ. 6:1077–1088.
1995.PubMed/NCBI
|
|
7
|
Huang P, Chandra V and Rastinejad F:
Structural overview of the nuclear receptor superfamily: Insights
into physiology and therapeutics. Annu Rev Physiol. 72:247–272.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Boehm MF, Heyman RA, Patel S, Stein RB and
Nagpal S: Section Review: Retinoids: Biological function and use in
the treatment of dermatological diseases: Pulmonary-allergy,
dermatological, gastrointestinal & arthritis. Expert Opin
Investig Drugs. 4:593–612. 2008. View Article : Google Scholar
|
|
9
|
Chandraratna RA: Tazarotene: The first
receptor-selective topical retinoid for the treatment of psoriasis.
J Am Acad Dermatol. 37(Suppl): S12–S17. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Duvic M, Nagpal S, Asano AT and
Chandraratna RA: Molecular mechanisms of tazarotene action in
psoriasis. J Am Acad Dermatol. 37(Suppl): S18–S24. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nagpal S, Patel S, Jacobe H, DiSepio D,
Ghosn C, Malhotra M, Teng M, Duvic M and Chandraratna RA:
Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene
in skin. J Invest Dermatol. 109:91–95. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Adams AE, Abu-Amer Y, Chappel J, Stueckle
S, Ross FP, Teitelbaum SL and Suva LJ: 1,25 dihydroxyvitamin D3 and
dexamethasone induce the cyclooxygenase 1 gene in
osteoclast-supporting stromal cells. J Cell Biochem. 74:587–595.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng Y, Luo S, Wang G, Peng Z, Zeng W,
Tan S, Xi Y and Fan J: Downregulation of tazarotene induced gene-2
(TIG2) in skin squamous cell carcinoma. Eur J Dermatol. 18:638–641.
2008.PubMed/NCBI
|
|
14
|
Livak and Schmittgen. Analysis of relative
gene expression data using real-time quantitative PCR and the
2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jing C, El-Ghany MA, Beesley C, Foster CS,
Rudland PS, Smith P and Ke Y: Tazarotene-induced gene 1 (TIG1)
expression in prostate carcinomas and its relationship to
tumorigenicity. J Natl Cancer Inst. 94:482–490. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
DiSepio D, Ghosn C, Eckert RL, Deucher A,
Robinson N, Duvic M, Chandraratna RA and Nagpal S: Identification
and characterization of a retinoid-induced class II tumor
suppressor/growth regulatory gene. Proc Natl Acad Sci USA.
95:14811–14815. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wittamer V, Franssen JD, Vulcano M,
Mirjolet JF, Le Poul E, Migeotte I, Brézillon S, Tyldesley R,
Blanpain C, Detheux M, et al: Specific recruitment of
antigen-presenting cells by chemerin, a novel processed ligand from
human inflammatory fluids. J Exp Med. 198:977–985. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luangsay S, Wittamer V, Bondue B, De Henau
O, Rouger L, Brait M, Franssen JD, de Nadai P, Huaux F and
Parmentier M: Mouse ChemR23 is expressed in dendritic cell subsets
and macrophages, and mediates an anti-inflammatory activity of
chemerin in a lung disease model. J Immunol. 183:6489–6499. 2009.
View Article : Google Scholar : PubMed/NCBI
|
